To validate the mRNA and protein levels of CPVL in glioma tissues of different grades, we conducted quantitative PCR (qPCR) and Western blotting in the low-grade (WHO I/II) and high-grade (WHO III/IV) glioma groups. The gene discussed is CPVL; the disease is glioma.